Browse Results

  • Principal Investigator: Hoffman, James

There are 3 clinical trial(s) matching your criteria.


Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE).

Investigator: James Hoffman

Institutional Protocol #: 20160548

National Clinical Trials Identifier: NCT01863550

Division: Cancer Center

Therapeutic Area: Leukemia, Lymphoma, and Myeloma

Phase: Phase III

Enrolling Since: 12/19/2016